Abstract
This research service covers the U.S. pulmonary arterial hypertension (PAH) markets and includes the four classes of PAH according to the New York Heart Association classification. The research service provides a market overview, competitive structure, market forecasts and market share analysis across these four segments.
Table of Contents
1 EXECUTIVE SUMMARY
- Executive Summary
- Executive Summary
2 TOTAL U.S. PULMONARY HYPERTENSION MARKETS
- Market Overview
- Introduction
- Market Segmentation
- Research Methodology
- Market Forecasts
- Patient Forecasts
- Pricing Forecasts
- Revenue Forecasts
- Competitive Analysis
- Competitive Structure
- Market Share Analysis
- Product Pipeline
3 U.S. CLASS I PULMONARY ARTERIAL HYPERTENSION MARKET
- Market Overview
- Introduction
- Market Engineering Measurements
- Market Forecasts
- Patient Forecasts
- Pricing Forecasts
- Revenue Forecasts
- Competitive Analysis
- Competitive Structure
- Market Share Analysis
4 U.S. CLASS II PULMONARY ARTERIAL HYPERTENSION MARKET
- Market Overview
- Introduction
- Market Engineering Measurements
- Market Forecasts
- Patient Forecasts
- Pricing Forecasts
- Revenue Forecasts
- Competitive Analysis
- Competitive Structure
- Market Share Analysis
5 U.S. CLASS III PULMONARY ARTERIAL HYPERTENSION MARKET
- Market Overview
- Introduction
- Market Engineering Measurements
- Market Forecasts
- Patient Forecasts
- Pricing Forecasts
- Revenue Forecasts
- Competitive Analysis
- Competitive Structure
- Market Share Analysis
6 U.S. CLASS IV PULMONARY ARTERIAL HYPERTENSION MARKET
- Market Overview
- Introduction
- Market Engineering Measurements
- Market Forecasts
- Patient Forecasts
- Pricing Forecasts
- Revenue Forecasts
- Competitive Analysis
- Competitive Structure
- Market Share Analysis
7 DECISION SUPPORT DATABASES
- Disease Incidence
- HIV Prevalence
- AIDS Incidence
- Coronary Heart Disease Prevalence
- Hypertension Prevalence
